Rejuvenate Bio is a gene therapy company focused on treating chronic diseases based upon its breakthrough technology developed at the Wyss Institute of Harvard University. Rejuvenate Bio utilizes gene therapy, proprietary targets, and tools to bring treatments to patients suffering from chronic conditions. The company is developing a pipeline of therapies with applications in cardiac and metabolic diseases.